ciprofloxacin has been researched along with Bancroftian Elephantiasis in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aglomasa, BC | 1 |
Adu-Asiamah, CK | 1 |
Asiedu, SO | 1 |
Kini, P | 1 |
Amewu, EKA | 1 |
Boahen, KG | 1 |
Wireko, S | 1 |
Amponsah, IK | 1 |
Boakye, YD | 1 |
Boamah, VE | 1 |
Kwarteng, A | 1 |
1 other study available for ciprofloxacin and Bancroftian Elephantiasis
Article | Year |
---|---|
Multi-drug resistant bacteria isolates from lymphatic filariasis patients in the Ahanta West District, Ghana.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Ceftazidime; Chlorampheni | 2022 |